EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Huntington´s disease – overview

Saga Briem, Thorsteinn Bjornsson, Vigdis Stefansdottir, Jon Johannes Jonsson, Olafur Arni Sveinsson

Laeknabladid · 05.05.2026 · 112 (05) · 216-222

DOI: 10.17992/lbl.2026.05.891 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Laeknabladid, online erschienen am 05.05.2026. Verfasst von Saga Briem und 4 weiteren Autor:innen. Beteiligte Einrichtung: University of Iceland, Faculty of Medicine. Hauptthemen laut MEDLINE: Huntington Disease.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Huntington’s disease (HD) is a rare, autosomal dominant neurodegenerative disorder characterized by progressive movement disturbances, psychiatric symptoms, and cognitive impairment. The disease is caused by an increased number of repeats of the cytosine–adenine–guanine (CAG) base sequence in the HTT gene, leading to the production of a huntingtin protein with toxic gain-of-function properties and the accumulation of protein aggregates in neurons, resulting in neurodegeneration. The prevalence of HD has previously been reported to be low in Iceland compared with other European countries. However, recent studies indicate an increased prevalence, likely due to improved diagnostic capabilities and greater use of genetic testing. Diagnosis is based on clinical evaluation, family history, and confirmation by genetic testing. Currently, no disease-modifying treatment is available, but symptomatic management and a multidisciplinary approach can improve patients’ functional abilities and quality of life. This review article discusses the epidemiology, genetics, clinical manifestations, diagnosis, and treatment of Huntington’s disease, with particular emphasis on recent Icelandic research findings and future prospects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Huntington DiseaseHumansGenetic Predisposition to DiseasePhenotypeRisk FactorsPrevalenceIcelandHuntingtin ProteinPredictive Value of TestsGenetic TestingTreatment Outcome

Stichwörter der Autor:innen

Huntington´s diseaseantisense oligonucleotideschoreaepidemiologytrinucleotide repeats

Substanzen

HTT protein, humanHuntingtin Protein

Autor:innen und Institutionen

  • University of Iceland, Faculty of Medicine.
  • Department of Neurology, Sahlgrenska University hospital, Gothenburg, Sweden.
  • Department of Genetics and Molecular Medicine, Landspitali University Hospital, Reykjavík, Iceland.
  • University of Iceland, Faculty of Medicine, Department of Genetics and Molecular Medicine, Landspitali University Hospital, Reykjavík, Iceland.
  • University of Iceland, Faculty of Medicine, Department of Neurology, University Hospital of Iceland, Reykjavik, Iceland.

Zitieren

APA

Briem, S., Bjornsson, T., Stefansdottir, V., Jonsson, J. J., & Sveinsson, O. A. (2026). Huntington´s disease – overview. Laeknabladid, 112(05), 216-222. https://doi.org/10.17992/lbl.2026.05.891

Vancouver

Briem S, Bjornsson T, Stefansdottir V, Jonsson JJ, Sveinsson OA. Huntington´s disease – overview. Laeknabladid. 2026;112(05):216-222. doi:10.17992/lbl.2026.05.891

BibTeX
@article{Briem2026,
  author = {Briem, Saga and Bjornsson, Thorsteinn and Stefansdottir, Vigdis and Jonsson, Jon Johannes and Sveinsson, Olafur Arni},
  title = {Huntington´s disease – overview},
  journal = {Laeknabladid},
  year = {2026},
  volume = {112},
  number = {05},
  pages = {216--222},
  doi = {10.17992/lbl.2026.05.891}
}
Kostenlos starten →